Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
2011

FXR Activation and Genetic Variation in Inflammatory Bowel Disease

Sample size: 2355 publication Evidence: moderate

Author Information

Author(s): Nijmeijer Rian M., Gadaleta Raffaella M., van Mil Saskia W. C., van Bodegraven Adriaan A., Crusius J. Bart A., Dijkstra Gerard, Hommes Daan W., de Jong Dirk J., Stokkers Pieter C. F., Verspaget Hein W., Weersma Rinse K., van der Woude C. Janneke, Stapelbroek Janneke M., Schipper Marguerite E. I., Wijmenga Cisca, van Erpecum Karel J., Oldenburg Bas

Primary Institution: University Medical Center Utrecht

Hypothesis

Is FXR activation repressed in the ileum and colon of inflammatory bowel disease patients in remission, and is genetic variation in FXR associated with IBD?

Conclusion

FXR activation in the ileum is decreased in patients with Crohn's colitis, potentially due to altered bile salt circulation or inflammatory signals, but not due to the studied genetic variations.

Supporting Evidence

  • mRNA expression of SHP was 50% lower in Crohn's colitis patients compared to controls.
  • No SNPs were significantly associated with IBD after correction for multiple testing.
  • Ileal FXR expression was unchanged, but SHP expression was reduced in Crohn's patients.

Takeaway

This study found that a protein called FXR, which helps control inflammation in the gut, doesn't work as well in people with Crohn's disease, but the genes studied didn't seem to cause this problem.

Methodology

mRNA expression of FXR and its target gene SHP was measured in biopsies from IBD patients and healthy controls, and genetic variations in FXR were analyzed in a large cohort.

Potential Biases

Potential type II error due to low prevalence of some SNPs.

Limitations

The study did not find significant associations after correcting for multiple testing, and some SNP assays failed.

Participant Demographics

Patients included 1162 with Crohn's disease and 1193 with ulcerative colitis, along with 853 healthy controls.

Statistical Information

P-Value

0.039

Confidence Interval

95% CI 1.02–1.71

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0023745

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication